These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Effect of the angiotensin converting enzyme inhibitor, perindopril, on heart rhythm variability and adrenoreactivity in patients with ischemic heart disease associated with duodenal ulcer]. Linnik SA; Naurbieva EN; Ponomareva EP Kardiologiia; 2007; 47(4):41-4. PubMed ID: 18260837 [No Abstract] [Full Text] [Related]
43. [Myocardial disease due to external cause]. Okada Y Nihon Rinsho; 2007 May; 65 Suppl 5():470-3. PubMed ID: 17571421 [No Abstract] [Full Text] [Related]
44. [Heart failure: an indication for beta blockaders]. Mahé I Presse Med; 1999 Jun; 28(20):1072. PubMed ID: 10394376 [No Abstract] [Full Text] [Related]
45. Beta-blockers given the go-ahead for treatment of heart failure. McMenemy MC Lancet; 1998 Sep; 352(9130):793. PubMed ID: 9737296 [No Abstract] [Full Text] [Related]
46. Bisoprolol improves survival in rats with heart failure. Watanabe K; Ohta Y; Inoue M; Ma M; Wahed MI; Nakazawa M; Hasegawa G; Naito M; Fuse K; Ito M; Kato K; Hanawa H; Kodama M; Aizawa Y J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S55-8. PubMed ID: 11811360 [TBL] [Abstract][Full Text] [Related]
47. The Cardiac Insufficiency Bisoprolol Study II. Drummond GA; Squire IB Lancet; 1999 Apr; 353(9161):1361. PubMed ID: 10218556 [No Abstract] [Full Text] [Related]
49. Successful heart failure therapy in mitochondrial disorder with noncompaction cardiomyopathy. Finsterer J; Stöllberger C; Gelpi E Int J Cardiovasc Imaging; 2006; 22(3-4):393-8. PubMed ID: 16502323 [TBL] [Abstract][Full Text] [Related]
50. Right ventricular function: a stepchild in the management of congestive heart failure. Hess M; Hurst D Congest Heart Fail; 2004; 10(3):152-3. PubMed ID: 15184730 [No Abstract] [Full Text] [Related]
51. Cost-effectiveness of screening for asymptomatic left ventricular dysfunction in childhood cancer survivors. Steingart RM; Liu JE; Oeffinger KC Ann Intern Med; 2014 May; 160(10):731-2. PubMed ID: 24842420 [No Abstract] [Full Text] [Related]
53. The Cardiac Insufficiency Bisoprolol Study II. Segev A; Mekori YA Lancet; 1999 Apr; 353(9161):1361. PubMed ID: 10218557 [No Abstract] [Full Text] [Related]
54. [Beta-adrenoblockers in arterial hypertension: focus on bisoprolol]. Osadchiĭ KK Kardiologiia; 2010; 50(1):84-9. PubMed ID: 20144165 [No Abstract] [Full Text] [Related]
55. Health economics of heart failure. Malek M Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV11-3. PubMed ID: 10574905 [No Abstract] [Full Text] [Related]
56. Obstacles to the initiation of beta blockers for heart failure in a specialised clinic within a district general hospital. Mahmoudi M; McDonagh S; Poole-Wilson P; Dubrey SW Heart; 2003 Apr; 89(4):442-4. PubMed ID: 12639877 [No Abstract] [Full Text] [Related]
57. The role of beta-blockade in modern cardiovascular therapy. Proceedings of the 3rd International Symposium on Bisoprolol. Barcelona, Spain, September 29-October 1, 1989. J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-212. PubMed ID: 11572202 [No Abstract] [Full Text] [Related]
58. 2000--a time to reflect, look forward, look back and worry about funding. Jackson G Int J Clin Pract; 2000; 54(1):3. PubMed ID: 10750249 [No Abstract] [Full Text] [Related]
59. [A case of typical flushing of atypical origin]. Durand JM; Gauthier C; Salas S Presse Med; 1999 Feb; 28(6):281. PubMed ID: 10073170 [No Abstract] [Full Text] [Related]